Arabic Arabic English English French French German German
dark

Geisinger becomes first in U.S. to treat cancer patients with Accuray Synchrony® technology on the Radixact® and CyberKnife® S7™ Systems to better target radiation treatments

Geisinger continues to bring advanced cancer care closer to home as it is the first hospital system in the U.S. to offer Accuray Incorporated’s (NASDAQ: ARAY) newest Synchrony ®  technology on both the CyberKnife ® S7™  and Radixact ®  Systems  Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Tetra Bio-Pharma Granted a Drug Establishment License to Distribute REDUVO Soft Gel Capsules in Canada

Next Post

The Australian TGA approves key label updates to Buvidal® for treatment of opioid dependence

Related Posts
Total
0
Share